Express Scripts (ESRX) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Express Scripts Announces 3rd Quarter Results; Increases 2015 Guidance Range
October 27, 2015 4:01 PM EDTST. LOUIS, Oct. 27, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 third quarter net income attributable to Express Scripts stockholders of $661.7 million, or $0.97 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.45 for the third quarter. 1
"With the rising cost of prescription drugs, we are continuing our mission to make medicine more affordable and accessible for clients and patients," said George Paz, Chairman and CEO. Â "Our innovative solutions, focused scale, specialized care and unmatched leadership manages cost more favorably for payers while improving health outcomes of... More



